fda decision tirzepatide for Weight Loss The FDA approval of #zepbound

Eligible Medicare beneficiaries may now get Wegovy, Zepbound or Foundayo for $50 per month.

In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively

Less Common / Serious Side Effects Palpitations Hypotension (rare, usually with high doses or other antihypertensives) Gingival hyperplasia (rare) Reflex tachycardia (minimal compared to other dihydropyridines) 5

Learn what causes "Ozempic teeth," how GLP-1 side effects affect your oral health, and what you can do.

Now it has been shown that limited experimental data can be used to train sophisticated machine learning models to accurately predict the activity of previously uncharacterized peptide ligand variants.

PlexusDx explains how to safely manage seasonal illness during weight loss therapy